About Synechion, Inc.


Synechion is derived from the Greek word synechia meaning an adhesion. Because we strive to provide "one-stop-shopping" for anyone interested in the science and business of adhesion prevention, we chose a name that conveys our interest and activities in this important medical problem.

Synechion, Inc. provides a broad range of professional services related to the development and commercialization of medical products reflecting over 28 years of research, development, and business experience in the pharmaceutical and medical arena by its principal, David Wiseman Ph.D.

Dr. Wiseman is an accomplished and recognized expert in the science and business of prevention of surgical adhesions with general expertise in preclinical, clinical, regulatory, and marketing aspects of medical products.
Since Synechion was founded in 1996, we have played a part in the development of almost all anti-adhesion products. We were able to get a number to clinical trial, or even to market.
As exciting is the broadening of our work to include conditions related to adhesions, including pelvic pain, interstitial cystitis and what we have called CAPPS. This lead to our founding of the world's first adhesions clinic and our work with PainShield® MD and the formation of a new company KevMed, LLC.

DISCLAIMER: The information provided here is not intended nor is implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
This Internet site provides links or references to other sites that are provided as a convenience to users of this site. Synechion, Inc. has no control over the content of such other sites and shall not be liable for any damages or injury arising from that content.